ArticleACG case reports journal2026
First Report of Successful Endoscopic Full-Thickness Plication Using the GERDx System to Treat Refractory GERD After Sleeve Gastrectomy.
Article in ACG case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastroesophageal reflux disease (GERD) frequently develops or worsens after sleeve gastrectomy (SG), and symptoms may persist despite optimal proton pump inhibitor (PPI) therapy due to postsurgical anatomical changes. Endoscopic full-thickness plication (eFTP) is a minimally invasive approach used to reinforce the gastroesophageal junction barrier. However, its feasibility after SG remains unclear given restricted retroflexion and reduced gastric compliance. This case represents the first reported use, to our knowledge, of GERDx eFTP in a post-SG patient with refractory GERD. The patient, a 40-year-old woman, had experienced severe GERD symptoms for 6 years after her SG and failed maximal PPI therapy. Evaluation revealed a 2-cm sliding hiatal hernia and pathological acid exposure. She underwent eFTP without any complications and had complete symptom resolution by 1 week, with successful discontinuation of PPIs at 3 months. This case demonstrates the technical feasibility of GERDx eFTP in a carefully selected post-SG patient with refractory GERD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.